A detailed history of Zeke Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 12,034 shares of BMY stock, worth $640,088. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,034
Previous 12,885 6.6%
Holding current value
$640,088
Previous $916,000 5.57%
% of portfolio
0.06%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $58,276 - $69,007
-851 Reduced 6.6%
12,034 $865,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $2 - $1,459
-19 Reduced 0.15%
12,885 $916,000
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $62,380 - $68,702
859 Added 7.13%
12,904 $994,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $740,526 - $887,957
12,045 New
12,045 $879,000
Q1 2020

Apr 24, 2020

SELL
$46.4 - $67.43 $861,044 - $1.25 Million
-18,557 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $543,179 - $708,529
11,038 Added 146.8%
18,557 $1.19 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $802,236 - $951,167
-18,757 Reduced 71.38%
7,519 $381,000
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $3,391 - $3,749
-76 Reduced 0.29%
26,276 $1.19 Million
Q1 2019

Apr 29, 2019

SELL
$45.12 - $53.8 $77,380 - $92,267
-1,715 Reduced 6.11%
26,352 $1.26 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $248,432 - $322,156
5,095 Added 22.18%
28,067 $1.46 Million
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $103,977 - $117,279
-1,884 Reduced 7.58%
22,972 $1.43 Million
Q2 2018

Jul 24, 2018

SELL
$50.53 - $62.98 $963,657 - $1.2 Million
-19,071 Reduced 43.42%
24,856 $1.38 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $639,646 - $736,361
10,675 Added 32.1%
43,927 $2.78 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $136,843 - $149,194
2,283 Added 7.37%
33,252 $2.04 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $1.71 Million - $1.97 Million
30,969
30,969 $1.97 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.